The dopamine D2 receptor (D2) system has been implicated in several neurological and psychiatric disorders, such as schizophrenia and Parkinson's disease. There are two isoforms of the D2 receptor: the long form (D2L) and the short form (D2S). The two isoforms are generated by alternative splicing of the same gene and differ only by 29 amino acids in their protein structures. Little is known about the distinct functions of either D2 isoform, primarily because selective pharmacological agents are not available. We generated D2L receptor-deficient (D2LϪ/Ϫ) mice by making a subtle mutation in the D2 gene. D2LϪ/Ϫ mice (which still express functional D2S) displayed reduced levels of locomotion and rearing behavior. Interestingly, haloperidol produced significantly less catalepsy and inhibition of locomotor activity in D2LϪ/Ϫ mice. These findings suggest that D2L and D2S may contribute differentially to the regulation of certain motor functions and to the induction of the extrapyramidal side effects associated with the use of typical antipsychotic drugs (e.g., haloperidol). Quinpirole induced a similar initial suppression of locomotor activity in both D2LϪ/Ϫ and wild-type mice. In addition, the D2S receptor in the mutant mice functioned approximately equally well as did D2L as an impulse-modulating autoreceptor. This suggests that the functions of these two isoforms are not dependent on the formation of receptor heterodimers. Our findings may provide novel information for potentially developing improved antipsychotic drugs.
Key words: dopamine D2L receptor; knock-out mice; locomotion; catalepsy; autoreceptor; haloperidol; D2S receptorAlterations in the dopamine D2 receptor (D2) system have been implicated in a variety of neurological and psychiatric disorders, including schizophrenia, Parkinson's disease, Huntington's disease, attention-deficit hyperactive disorder, and drug addiction (Sibley et al., 1993;Graybiel, 1995;Jaber et al., 1996;Nestler and Aghajanian, 1997;Koob et al., 1998). Parkinsonian patients exhibit deficits in motor function, which are attributed to the degeneration of dopaminergic neurons in the substantia nigra (SN) (Hornykiewicz, 1966). Schizophrenic patients exhibit psychotic symptoms, which may partially result from dysfunction of the mesocortical and hippocampal dopamine (DA) systems (Carlsson and Carlsson, 1990;Jaskiw and Weinberger, 1992). The drugs typically used to treat schizophrenia and Parkinson's disease are D2 antagonists or agonists, respectively, suggesting that the D2 receptor plays an important role in these two neuropsychiatric diseases.Two isoforms of the D2 receptor [the long form (D2L) and the short form (D2S)] have been identified (Bunzow et al., 1988;Dal Toso et al., 1989;Giros et al., 1989;Monsma et al., 1989;Chio et al., 1990;Mack et al., 1991). The D2L and D2S receptors are generated from the same gene by alternative splicing. The D2L receptor has a 29 amino acid insertion in the third cytoplasmic loop of the protein, and this insertion is absent in the D2S receptor. The t...